Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03303716 · ClinicalTrials.gov registry record
ASXL-Related Disorders Natural History Study
A clinical trial of Bainbridge-Ropers Syndrome and Bohring-Opitz Syndrome, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT03303716 is a study of Bainbridge-Ropers Syndrome and Bohring-Opitz Syndrome that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03303716, a study of Bainbridge-Ropers Syndrome and Bohring-Opitz Syndrome, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
A registry focused on the natural history, management and treatment of patients with Bohring-Opitz Syndrome (ASXL1), Shashi-Pena Syndrome (ASXL2) and Bainbridge-Ropers Syndrome (ASXL3).
Conditions Studied
Study Locations (1)
California
- University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-09-20 |
| Est. Completion | 2037-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03303716
The ClinicalTrials.gov registry entry for NCT03303716 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Bainbridge-Ropers Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT03303716 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03303716 about?
NCT03303716 is a clinical study titled "ASXL-Related Disorders Natural History Study". A registry focused on the natural history, management and treatment of patients with Bohring-Opitz Syndrome (ASXL1), Shashi-Pena Syndrome (ASXL2) and Bainbridge-Ropers Syndrome (ASXL3).
What is the current status of trial NCT03303716?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2017-09-20. Estimated completion is 2037-09.
What conditions does trial NCT03303716 study?
This clinical trial studies the following conditions: Bainbridge-Ropers Syndrome, Bohring-Opitz Syndrome, ASXL1 Gene Mutation, Shashi-Pena Syndrome, ASXL2 Gene Mutation.
Who is sponsoring clinical trial NCT03303716?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03303716 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bainbridge-Ropers Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.